Proposal of Modified HIL-indices for Determining Hemolysis, Icterus and Lipemia Interference on the Beckman Coulter AU5800 Automated Platform
Background: The amount of interference due to hemolysis, bilirubin, and lipemia can be measured on the AU5800 autoanalyzer (Beckman Coulter, USA) by spectrophotometry. This is reported as semi-quantitative indices, specifically H-index, I-index, and L-index, respectively. In this study, we evaluated...
Saved in:
Published in | Laboratory Medicine Online Vol. 7; no. 2; pp. 66 - 72 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
대한진단검사의학회
01.04.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 2093-6338 2093-6338 |
DOI | 10.3343/lmo.2017.7.2.66 |
Cover
Abstract | Background: The amount of interference due to hemolysis, bilirubin, and lipemia can be measured on the AU5800 autoanalyzer (Beckman Coulter, USA) by spectrophotometry. This is reported as semi-quantitative indices, specifically H-index, I-index, and L-index, respectively. In this study, we evaluated the impact of interference using chemistry assays and established the concentration of interfering substances and HIL-index above which analytically significant interference exists, according to CLSI guidelines C56-A and EP7-A2.
Methods: Pooled sera including different concentrations of analytes were prepared and mixed with hemoglobin, bilirubin, or Intralipid. These samples were then tested for 35 clinical chemistry analytes by AU5800 and the bias based on interferent concentrations was computed. The interferent concentration above which significant interference exists was calculated from the 50% within-subject biological variation (desirable analytic goal), and the corresponding index was assigned.
Results: Among 35 items evaluated, interference was detected for 12 analytes by hemoglobin, 7 analytes by bilirubin, and 12 analytes by Intralipid. We proposed HIL-index1 and HIL-index2 for each analyte according to 2 different medical decision levels. HIL-index1 and HIL-index2 were considered more reasonable criteria than the HIL-index from the manufacturer’s technical document (HIL-indexTD). This is because HIL-indexTD was empirically set to 5% or 10%, and had a wide tolerance range, which was not sufficient to reflect the presence of interference, compared to HIL-index1 and HIL-index2.
Conclusions: We have demonstrated hemoglobin, bilirubin, and Intralipid interferences according to CLSI guidelines using the desirable analytic goal. Our results provide applicable information for Beckman Coulter automated chemistry analyzers. KCI Citation Count: 0 |
---|---|
AbstractList | Background: The amount of interference due to hemolysis, bilirubin, and lipemia can be measured on the AU5800 autoanalyzer (Beckman Coulter, USA) by spectrophotometry. This is reported as semi-quantitative indices, specifically H-index, I-index, and L-index, respectively. In this study, we evaluated the impact of interference using chemistry assays and established the concentration of interfering substances and HIL-index above which analytically significant interference exists, according to CLSI guidelines C56-A and EP7-A2.
Methods: Pooled sera including different concentrations of analytes were prepared and mixed with hemoglobin, bilirubin, or Intralipid. These samples were then tested for 35 clinical chemistry analytes by AU5800 and the bias based on interferent concentrations was computed. The interferent concentration above which significant interference exists was calculated from the 50% within-subject biological variation (desirable analytic goal), and the corresponding index was assigned.
Results: Among 35 items evaluated, interference was detected for 12 analytes by hemoglobin, 7 analytes by bilirubin, and 12 analytes by Intralipid. We proposed HIL-index1 and HIL-index2 for each analyte according to 2 different medical decision levels. HIL-index1 and HIL-index2 were considered more reasonable criteria than the HIL-index from the manufacturer’s technical document (HIL-indexTD). This is because HIL-indexTD was empirically set to 5% or 10%, and had a wide tolerance range, which was not sufficient to reflect the presence of interference, compared to HIL-index1 and HIL-index2.
Conclusions: We have demonstrated hemoglobin, bilirubin, and Intralipid interferences according to CLSI guidelines using the desirable analytic goal. Our results provide applicable information for Beckman Coulter automated chemistry analyzers. KCI Citation Count: 0 |
Author | Lim, Yong Kwan Cha, Young Joo |
Author_xml | – sequence: 1 givenname: Yong Kwan surname: Lim fullname: Lim, Yong Kwan organization: Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, Korea – sequence: 2 givenname: Young Joo surname: Cha fullname: Cha, Young Joo organization: Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, Korea |
BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002212478$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp1UblOxDAUtBBInDWtWyQSHDvOUS7LsZEWgRDU1lv7GaxN7JWdLfgI_plwFAiJap7meFPMIdn1wSMhpwXLhSjFRT-EnLOizuuc51W1Qw44a0VWCdHs_rr3yUlKbsVYI1hdtu0BeX-IYRMS9DRYeheMsw4NXXTLzHnjNCZqQ6RXOGIcnHf-hS5wCP1bcumcdnqit4mCN3TpNjg4oJ2fOIsRvUYaPB1fkV6iXg_g6Txs-0mls2fZMEZn2zEMME59Dz2MU89wTPYs9AlPfvCIPN9cP80X2fL-tpvPlpkuOGuyUutGYstNBSgtRwN1y229kqUEURiBzCCTgq9M2TZtLaoV1JaD0KUB2YIUR-Ts-6-PVq21UwHcF74EtY5q9vjUqUJIURTN5JXfXh1DShGt0m6E0QU_RnC9Kpj6nEBNE6jPCVStuKqqKXfxJ7eJboD49m_iA6cKjMQ |
CitedBy_id | crossref_primary_10_1515_tjb_2018_0462 crossref_primary_10_1016_j_plabm_2023_e00347 crossref_primary_10_3390_diagnostics12020510 |
Cites_doi | 10.1177/000456329703400601 10.1093/clinchem/40.11.1996 10.11613/BM.2014.008 10.1258/acb.2010.010187 10.1373/clinchem.2004.040154 10.1515/CCLM.2006.067 10.1016/j.cccn.2003.12.032 10.1093/clinchem/43.6.1048 10.3343/alm.2015.35.3.341 10.1093/clinchem/35.5.837 10.1258/000456307780945633 10.1007/s00769-009-0630-8 10.1177/000456329703400103 10.1016/j.cca.2011.04.034 10.1373/clinchem.2004.038075 10.1515/cclm-2015-0067 |
ContentType | Journal Article |
DBID | AAYXX CITATION ACYCR |
DOI | 10.3343/lmo.2017.7.2.66 |
DatabaseName | CrossRef Korean Citation Index |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2093-6338 |
EndPage | 72 |
ExternalDocumentID | oai_kci_go_kr_ARTI_1353118 10_3343_lmo_2017_7_2_66 |
GroupedDBID | 5-W 8JR 8XY AAYXX ACYCR ALMA_UNASSIGNED_HOLDINGS CITATION EF. |
ID | FETCH-LOGICAL-c1208-4cc85e92d6ae5f2eda792f7b545a31d3e0de0532bd4989736ba7f2a3c4da59a53 |
ISSN | 2093-6338 |
IngestDate | Tue Nov 21 21:46:17 EST 2023 Thu Apr 24 23:08:46 EDT 2025 Tue Jul 01 04:32:38 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1208-4cc85e92d6ae5f2eda792f7b545a31d3e0de0532bd4989736ba7f2a3c4da59a53 |
Notes | G704-SER000002688.2017.7.2.001 |
PageCount | 7 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_1353118 crossref_citationtrail_10_3343_lmo_2017_7_2_66 crossref_primary_10_3343_lmo_2017_7_2_66 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-04 |
PublicationDateYYYYMMDD | 2017-04-01 |
PublicationDate_xml | – month: 04 year: 2017 text: 2017-04 |
PublicationDecade | 2010 |
PublicationTitle | Laboratory Medicine Online |
PublicationYear | 2017 |
Publisher | 대한진단검사의학회 |
Publisher_xml | – name: 대한진단검사의학회 |
References | Dimeski (10.3343/lmo.2017.7.2.66_ref2) 2008; 29 Glick (10.3343/lmo.2017.7.2.66_ref3) 1989; 35 Nikolac (10.3343/lmo.2017.7.2.66_ref13) 2014; 24 Sandberg (10.3343/lmo.2017.7.2.66_ref17) 2015; 53 Huang (10.3343/lmo.2017.7.2.66_ref20) 1997; 43 Kroll (10.3343/lmo.2017.7.2.66_ref1) 1994; 40 Kroll (10.3343/lmo.2017.7.2.66_ref9) 2004; 50 Ji (10.3343/lmo.2017.7.2.66_ref5) 2011; 412 Clinical and Laboratory Standards Institute (10.3343/lmo.2017.7.2.66_ref8) 2005 Fraser (10.3343/lmo.2017.7.2.66_ref11) 1997; 34 10.3343/lmo.2017.7.2.66_ref12 Young (10.3343/lmo.2017.7.2.66_ref16) 1997; 34 Steen (10.3343/lmo.2017.7.2.66_ref4) 2006; 44 Yoo (10.3343/lmo.2017.7.2.66_ref18) 2015; 35 Clinical and Laboratory Standards Institute (10.3343/lmo.2017.7.2.66_ref7) 2012 Ricos (10.3343/lmo.2017.7.2.66_ref15) 2007; 44 Bornhorst (10.3343/lmo.2017.7.2.66_ref19) 2004; 50 Steen (10.3343/lmo.2017.7.2.66_ref6) 2011; 48 Fraser (10.3343/lmo.2017.7.2.66_ref10) 2004; 346 Petersen (10.3343/lmo.2017.7.2.66_ref14) 2010; 15 |
References_xml | – volume: 34 start-page: 579 issue: Pt 6 year: 1997 ident: 10.3343/lmo.2017.7.2.66_ref16 publication-title: Ann Clin Biochem doi: 10.1177/000456329703400601 – volume: 40 start-page: 1996 year: 1994 ident: 10.3343/lmo.2017.7.2.66_ref1 publication-title: Clin Chem doi: 10.1093/clinchem/40.11.1996 – volume: 24 start-page: 57 year: 2014 ident: 10.3343/lmo.2017.7.2.66_ref13 publication-title: Biochem Med (Zagreb) doi: 10.11613/BM.2014.008 – volume: 29 start-page: S43 issue: Suppl 1 year: 2008 ident: 10.3343/lmo.2017.7.2.66_ref2 publication-title: Clin Biochem Rev – volume: 48 start-page: 170 year: 2011 ident: 10.3343/lmo.2017.7.2.66_ref6 publication-title: Ann Clin Biochem doi: 10.1258/acb.2010.010187 – volume: 50 start-page: 2197 year: 2004 ident: 10.3343/lmo.2017.7.2.66_ref19 publication-title: Clin Chem doi: 10.1373/clinchem.2004.040154 – volume: 44 start-page: 413 year: 2006 ident: 10.3343/lmo.2017.7.2.66_ref4 publication-title: Clin Chem Lab Med doi: 10.1515/CCLM.2006.067 – volume-title: Interference testing in clinical chemistry; approved guideline year: 2005 ident: 10.3343/lmo.2017.7.2.66_ref8 – volume: 346 start-page: 19 year: 2004 ident: 10.3343/lmo.2017.7.2.66_ref10 publication-title: Clin Chim Acta doi: 10.1016/j.cccn.2003.12.032 – volume: 43 start-page: 1048 year: 1997 ident: 10.3343/lmo.2017.7.2.66_ref20 publication-title: Clin Chem doi: 10.1093/clinchem/43.6.1048 – ident: 10.3343/lmo.2017.7.2.66_ref12 – volume: 35 start-page: 341 year: 2015 ident: 10.3343/lmo.2017.7.2.66_ref18 publication-title: Ann Lab Med doi: 10.3343/alm.2015.35.3.341 – volume: 35 start-page: 837 year: 1989 ident: 10.3343/lmo.2017.7.2.66_ref3 publication-title: Clin Chem doi: 10.1093/clinchem/35.5.837 – volume-title: Hemolysis, icterus, and lipemia/turbidity indices as indicators of interference in clinical laboratory analysis; approved guideline year: 2012 ident: 10.3343/lmo.2017.7.2.66_ref7 – volume: 44 start-page: 343 year: 2007 ident: 10.3343/lmo.2017.7.2.66_ref15 publication-title: Ann Clin Biochem doi: 10.1258/000456307780945633 – volume: 15 start-page: 323 year: 2010 ident: 10.3343/lmo.2017.7.2.66_ref14 publication-title: Accred Qual Assur doi: 10.1007/s00769-009-0630-8 – volume: 34 start-page: 8 issue: Pt 1 year: 1997 ident: 10.3343/lmo.2017.7.2.66_ref11 publication-title: Ann Clin Biochem doi: 10.1177/000456329703400103 – volume: 412 start-page: 1550 year: 2011 ident: 10.3343/lmo.2017.7.2.66_ref5 publication-title: Clin Chim Acta doi: 10.1016/j.cca.2011.04.034 – volume: 50 start-page: 1968 year: 2004 ident: 10.3343/lmo.2017.7.2.66_ref9 publication-title: Clin Chem doi: 10.1373/clinchem.2004.038075 – volume: 53 start-page: 833 year: 2015 ident: 10.3343/lmo.2017.7.2.66_ref17 publication-title: Clin Chem Lab Med doi: 10.1515/cclm-2015-0067 |
SSID | ssib008307499 |
Score | 1.9879911 |
Snippet | Background: The amount of interference due to hemolysis, bilirubin, and lipemia can be measured on the AU5800 autoanalyzer (Beckman Coulter, USA) by... |
SourceID | nrf crossref |
SourceType | Open Website Enrichment Source Index Database |
StartPage | 66 |
SubjectTerms | 임상병리학 |
Title | Proposal of Modified HIL-indices for Determining Hemolysis, Icterus and Lipemia Interference on the Beckman Coulter AU5800 Automated Platform |
URI | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002212478 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Laboratory Medicine Online, 2017, 7(2), , pp.66-72 |
journalDatabaseRights | – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2093-6338 dateEnd: 99991231 omitProxy: true ssIdentifier: ssib008307499 issn: 2093-6338 databaseCode: 5-W dateStart: 20110101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NbxMxELXScuGCQIAoUGQhDkhhl8T2fvhYAigtCeqhEeVk2bt2FeVjq5CoEif-AP-ZmfXuZolSqXDZRE4yu8o8jZ894zeEvLFaGuaMDlzueoEwlgfSCRdIARG5Z-CTMns-_hoPJ-LsMrrsdH61qpY2axNmP_eeK_kfr8IY-BVPyf6DZxujMADvwb9wBQ_D9U4-PscWBz88nRwX-dQhnxyejgJMRGOpFdYQfqwKXnBPYGgXRalBUoYG1GneeI3m0fTaLqbabxDW0rM-j9D9YLMZ7vQPsAU1ltRPIuB_3ZPNugC6C3c8n-s1ct820R15cGEGf1yl77te1rQpAfJ9nL9js6MvN1uQDnwKqgxD3bOiaO9LwFy3LWcpwxfrSR7E3Gu3hHbPWBV_kxbMWCuW-m4suyGec4FSE_MFntzsJ2ESsjDeI6a9M8k1pYew6EETCgwoNKASxVQcH5B7LIlj7IERBd-aiJRCCBRlE9Lm0b0-FNp4v_MQf1Gbg-XKtZjKxUPyoFpi0BOPl0ekY5ePye8aK7RwtMYKbWGFggdpCyu0wco7WiGFAlJohRTaRgotlhSQQiuk0Aop1COFNkihNVKekMnnTxeDYVC14giyPuulgciyNLKS5bG2kWM214lkLjHAvzXv59z28rLHiMmFTGXCY6MTxzTPRK4jqSP-lBwui6V9RmjuUlx2GJnIXHAjNYthThBAfCEuMO2OSFj_iyqrdOqxXcpc3eK6I_K2-cG1l2i5_auvwS1qlk0Vyqrj61WhZisFi8dThS1gYL39_O72XpD7W-i_JIfr1cYeA0ldm1cljv4AFN6UCw |
linkProvider | Korean Association of Medical Journal Editors |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Proposal+of+Modified+HIL-indices+for+Determining+Hemolysis%2C+Icterus+and+Lipemia+Interference+on+the+Beckman+Coulter+AU5800+Automated+Platform&rft.jtitle=Laboratory+Medicine+Online&rft.au=Lim%2C+Yong+Kwan&rft.au=Cha%2C+Young+Joo&rft.date=2017-04-01&rft.issn=2093-6338&rft.eissn=2093-6338&rft.volume=7&rft.issue=2&rft.spage=66&rft_id=info:doi/10.3343%2Flmo.2017.7.2.66&rft.externalDBID=n%2Fa&rft.externalDocID=10_3343_lmo_2017_7_2_66 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2093-6338&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2093-6338&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2093-6338&client=summon |